Systemic shift in genomic aberrations in breast carcinomas during neoadjuvant chemotherapy in combination with bevacizumab

被引:0
|
作者
Moller, Elen K.
Nord, Silje
Wedge, David
Lngjaerde, Ole Christian
Silwal-Pandit, Laxmi
Gythfeld, Hedda Vdl
Vollan, Hans Kristian M.
Fleischer, Thomas
Krohn, Marit
Schlichting, Ellen
Borgen, Elin
Garred, Oystein
Holmen, Marit M.
Wist, Erik
Naume, Bjorn
Loo, Peter V.
Borresen-Dale, Anne-Lise
Engebraten, Olav
Kristensen, Vessela
机构
关键词
D O I
10.1158/1538-7445.AM2016-LB-337
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LB-337
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab
    Jabeen, Shakila
    Zucknick, Manuela
    Nome, Marianne
    Dannenfelser, Ruth
    Fleischer, Thomas
    Kumar, Surendra
    Luders, Torben
    Gythfeldt, Hedda von der Lippe
    Troyanskaya, Olga
    Kyte, Jon Amund
    Borresen-Dale, Anne-Lise
    Naume, Bjorn
    Tekpli, Xavier
    Engebraaten, Olav
    Kristensen, Vessela
    [J]. ONCOIMMUNOLOGY, 2018, 7 (11):
  • [42] Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer
    Caudle, Abigail S.
    Gonzalez-Angulo, Ana M.
    Hunt, Kelly K.
    Liu, Ping
    Pusztai, Lajos
    Symmans, W. Fraser
    Kuerer, Henry M.
    Mittendorf, Elizabeth A.
    Hortobagyi, Gabriel N.
    Meric-Bernstam, Funda
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) : 1821 - 1828
  • [43] Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer
    Caudle, A. S.
    Gonzalez-Angulo, A. M.
    Kelly, H. K.
    Liu, P.
    Pusztai, L.
    Symmans, W. F.
    Kuerer, H. M.
    Mittendorf, E. A.
    Hortobagyi, G. N.
    Meric-Bernstam, F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] The clonal evolution of a breast tumor during neoadjuvant chemotherapy and metastasis
    Litviakov, N. V.
    Cherdyntseva, N.
    Ibragimova, M. K.
    Tsyganov, M.
    Doroshenko, A. V.
    Kazantseva, P.
    Kzhyshkowska, J.
    Slonimskaya, E.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [45] Body composition change during neoadjuvant chemotherapy for breast cancer
    Jang, Min Kyeong
    Park, Seho
    Park, Chang
    Doorenbos, Ardith Z.
    Go, Jieon
    Kim, Sue
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Neoadjuvant chemotherapy for patients with breast cancer during pregnancy (BCP).
    Loibl, Sibylle
    Han, Sileny
    Mayer, Kristin
    MacMillan, Kristina
    Gyapong, Samuel
    Luebbe, Kristina
    Weiss, Cornelia
    Schreiber, Kathi
    Witzel, Isabel
    Mueller, Volkmar
    Schneeweiss, Andreas
    Mundhenke, Christoph
    Waldhoer, Christine
    Rezek, Daniela
    Vogt, Nadine
    Strobel, Stefanie
    Parokonnaya, Anna
    Nekljudova, Valentina
    Amant, Frederic
    Von Minckwitz, Gunter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] Patterns of loss of heterozygosity in breast carcinoma during neoadjuvant chemotherapy
    Oudin, Claire
    Bonnetain, Frank
    Boidot, Romain
    Vegran, Frederique
    Soubeyrand, Marie-Sophie
    Arnould, Laurent
    Riedinger, Jean-Marc
    Lizard-Nacol, Sarab
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 30 (05) : 1145 - 1151
  • [48] MR tompgraphy of the breast: Changes in sensitivity during neoadjuvant chemotherapy
    Rieber, A
    Rosenthal, H
    Zeitler, H
    Tomozak, RJ
    Kreienberg, R
    Brambs, H
    [J]. RADIOLOGY, 1996, 201 : 612 - 612
  • [49] PREDICTIVE FACTORS OF NO RESPONSE DURING NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER
    Jo, J.
    Yoo, C.
    Kim, J. -E.
    Ahn, J. -H.
    Kim, S. -B.
    Kim, H. -H.
    Cha, J. H.
    Shin, H. J.
    Ahn, S. -H.
    Son, B. H.
    Lee, J. W.
    Kim, H. J.
    Gong, G.
    Jung, K. H.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 40 - 40
  • [50] Impact of delayed neoadjuvant systemic chemotherapy on survival among breast cancer patients
    Mac Gregor, M. Chavez
    Lei, X.
    Gagliato, D.
    Valero, V.
    Barcenas, C.
    Hortobagyi, G. N.
    Giordano, S. H.
    [J]. ANNALS OF ONCOLOGY, 2019, 30